Pharmaceutical compositions
OwnerDorothea Ledergerberinventor
Life of this patent
Estimating the term…
Abstract
The invention relates to pharmaceutical compositions comprising an ascomycin in dissolved form and a pharmaceutically acceptable cellulose derivative for prevention or reduction of crystal growth.
Claims10
A pharmaceutical composition comprising an ascomycin or a derivative thereof and a pharmaceutically acceptable cellulose derivative for inhibiting or reducing crystal growth.
A pharmaceutical composition in the form of an emulsion or ointment comprising an ascomycin or a derivative thereof in dissolved form and a pharmaceutically acceptable cellulose derivative.
A composition according to any preceding claim wherein the cellulose derivative is present in an amount of about 0.1% to about 5% by weight, based on the total weight of the composition.
A composition according to any preceding claim wherein the cellulose derivative is hydroxypropyl methyl cellulose.
A composition according to any preceding claim for use in the treatment of inflammatory or hyperproliferative skin diseases or of cutaneous manifestations of immunologically-mediated diseases.
Use of a pharmaceutically acceptable cellulose derivative to inhibit or reduce crystal growth of ascomycin or of a derivative thereof a pharmaceutical composition comprising an ascomycin or a derivative thereof.
A method of preventing or reducing crystal growth of an ascomycin or of a derivative thereof in a pharmaceutical composition comprising an ascomycin or a derivative thereof in dissolved form by admixing a pharmaceutically acceptable cellulose derivative thereto.
Dependencies are inferred from the claim text.